< Back to latest news & events

Event

Medilink and UClan event: Overcoming major issues of commercialisation (regulation and internationalisation)

February 2022

Event date: 3rd March 2022

HGF Partner & Head of Electronics Dr Chris Benson is attending and speaking at the Medilink and University of Central Lancashire event: Overcoming major issues of commercialisation (regulation and internationalisation) on 3rd March in Preston.

This event is aimed at pre-revenue and early stage start-up life science companies, as well as clinicians and academics who are looking to commercialise their ideas and staff looking to update their knowledge in these important areas. The event can be attended in person or online.

Dr Chris Benson will be speaking in the 3pm session ‘Key considerations – professional services providers: legal, IP & insurance‘.

Find out more about the event here.

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

INTA 2025 Annual Meeting Live

The HGF European team will be attending the INTA Annual Meeting Live, which will take place on 17th-21st May in San Diego, US. The conference will connect some of the …

Read article

HGF wins big at the Managing IP EMEA Awards Ceremony 2025

The Annual Managing IP Awards: EMEA Awards 2025 were announced last night, and HGF are proud to have won 7 awards. The Managing IP Awards are highly recognised and respected …

Read article

Plant Patent Infringement in the US Relies on Evidence of Asexual Reproduction

A recent case in the US District Court for the Northern District of Texas (Dallas Division) once again highlights how important the initial pleadings and evidence in patent infringement cases …

Read article

Exam Success at HGF!

HGF is pleased to announce that several of our attorneys have passed their UK Advanced Patent exams! In no specific order, we would like to say well done and a …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article